Canada suspends private plasma clinics after breaches

A private plasma operator has halted collections across its network of 17 clinics in Canada after federal health regulators issued a formal notice of non-compliance, officials said. Authorities said the stoppage followed investigations and inspections that identified operational shortcomings at multiple sites. The company described the move as a voluntary pause, while officials linked the timing and basis of the shutdown to the regulator’s findings.

Officials said inspection results pointed to recurring issues affecting routine operations. They cited gaps in staff training, failures to follow standard operating procedures, and documentation errors. Regulators also raised concerns about inaccurate records and problems that were not fully corrected after earlier findings, officials said.

Regulators cite training, procedures, and record reliability Officials said the notice of non-compliance centered on Officials said the notice of non-compliance centered on whether day-to-day practices at the clinics met required standards. Regulators reviewed whether staff were properly trained, whether written procedures were applied consistently, and whether documentation was dependable for safe operations and traceability, according to officials. Authorities said inspections also recorded repeated shortcomings in how previous deficiencies were addressed. Officials described the record as showing ongoing failures to resolve issues that had already been identified, which contributed to the decision to issue a formal notice of non-compliance. Safety-alarm response and screening questions add pressure Regulators highlighted cases in which staff did not respond when safety alarms sounded during the apheresis process, officials said. Authorities said these examples raised concerns about whether procedures were being applied consistently during plasma collection.

Officials said patient advocates questioned medical screening protocols and pointed to discrepancies in how information had been reported. Authorities said these concerns formed part of the broader compliance picture that fed into the non-compliance notice.

Manitoba donor deaths keep oversight in focus

The shutdown comes as public attention continues on the deaths of two donors in Manitoba between October 2025 and January 2026. Federal authorities previously said no direct link had been established between the plasma donation process and the fatalities. Even so, officials said advocates have continued to press for clarity on how screening steps were carried out and how related events were documented.

Officials said the overlap of heightened scrutiny and Officials said the overlap of heightened scrutiny and regulatory action has sustained attention on how clinics monitor donor safety and how key information is recorded during collection.

Supply impact and unanswered questions on restart timing

Authorities said the pause disrupts the private-sector supply chain for plasma collection, while emphasizing that the broader national blood and plasma supply remains secure. The operator said it is stopping operations to address regulator concerns and align with national blood safety standards.

Officials said uncertainty remains about how long the clinics will remain inactive, what will be required before collection can resume, and which deficiencies regulators view as most urgent. For donors and patients, officials said immediate questions focus on verification: what corrective actions will be taken, how compliance will be checked, and when regulators will consider the network ready to restart.